Company: MDCXW
Filing Date: 2025-05-01
Form Type: DRS
Source: 0001062993-25-008292
Chunk: 217

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-01
Form: DRS
Chunk 217
---
 Weighted average number of common shares outstanding - basic and diluted   |   |                9,619,184 |   |   |  3,479,494 |   |

The accompanying notes are an integral part of these consolidated financial statements. F-6

Medicus Pharma Ltd.
Consolidated Statements of Changes in Shareholders' Equity
(expressed in United States dollars, except number of shares)

|                                                                                                                        |     |            |     | Common shares |     |      Additional 
 paid-in capital |     | Accumulated 
 deficit     |   |     |       Total |   |
|:-----------------------------------------------------------------------------------------------------------------------|:----|-----------:|:----|--------------:|:----|----------------:|:----|:------------|:--|:----|------------:|:--|
|                                                                                                                        |     |          # |     |             $ |     |               $ |     | $           |   |     |           $ |   |
| Balance as of December 31, 2022                                                                                        |     |  1,884,900 |     |       194,538 |     |               - |     | (12,383,622 | ) |     | (12,189,084 | ) |
| Issuance of common shares upon acquisition of Interactive Capital Partners Ltd.                                        |     |    287,471 |     |             - |     |               - |     | (50,000     | ) |     |     (50,000 | ) |
| Issuance of common shares upon conversion of preferred shares                                                          |     |  3,952,366 |     |    10,506,903 |     |               - |     | -           |   |     |  10,506,903 |   |
| Issuance of common shares upon conversion of promissory notes                                                          |     |    647,224 |     |     2,799,859 |     |               - |     | -           |   |     |   2,799,859 |   |
| Issuance of common shares upon conversion of note payable                                                              |     |     27,286 |     |       150,000 |     |               - |     | -           |   |     |     150,000 |   |
| Issuance of common shares in connection with financing                                                                 |     |  1,277,426 |     |     5,109,950 |